Dermapharm Holding SE Statistics

Total Valuation

LON:0A5J has a market cap or net worth of GBP 1.62 billion. The enterprise value is 2.39 billion.

Market Cap	1.62B
Enterprise Value	2.39B

Important Dates

The next estimated earnings date is Tuesday, August 26, 2025.

Earnings Date	Aug 26, 2025
Ex-Dividend Date	Jun 27, 2025

Share Statistics

Current Share Class	53.84M
Shares Outstanding	n/a
Shares Change (YoY)	-0.06%
Shares Change (QoQ)	+0.51%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	8.85M

Valuation Ratios

The trailing PE ratio is 18.74 and the forward PE ratio is 14.62.

PE Ratio	18.74
Forward PE	14.62
PS Ratio	1.62
PB Ratio	3.02
P/TBV Ratio	n/a
P/FCF Ratio	14.79
P/OCF Ratio	11.25
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 10.81, with an EV/FCF ratio of 21.73.

EV / Earnings	27.53
EV / Sales	2.31
EV / EBITDA	10.81
EV / EBIT	12.53
EV / FCF	21.73

Financial Position

The company has a current ratio of 2.05, with a Debt / Equity ratio of 1.55.

Current Ratio	2.05
Quick Ratio	0.80
Debt / Equity	1.55
Debt / EBITDA	3.91
Debt / FCF	7.58
Interest Coverage	3.93

Financial Efficiency

Return on equity (ROE) is 16.57% and return on invested capital (ROIC) is 8.42%.

Return on Equity (ROE)	16.57%
Return on Assets (ROA)	6.40%
Return on Invested Capital (ROIC)	8.42%
Return on Capital Employed (ROCE)	12.15%
Revenue Per Employee	277,920
Profits Per Employee	24,002
Employee Count	3,610
Asset Turnover	0.56
Inventory Turnover	1.31

Taxes

In the past 12 months, LON:0A5J has paid 46.81 million in taxes.

Income Tax	46.81M
Effective Tax Rate	35.45%

Stock Price Statistics

The stock price has decreased by -1.27% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-1.27%
50-Day Moving Average	35.92
200-Day Moving Average	36.63
Relative Strength Index (RSI)	47.08
Average Volume (20 Days)	20,507

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, LON:0A5J had revenue of GBP 1.00 billion and earned 86.65 million in profits. Earnings per share was 1.61.

Revenue	1.00B
Gross Profit	627.29M
Operating Income	183.41M
Pretax Income	132.02M
Net Income	86.65M
EBITDA	207.67M
EBIT	183.41M
Earnings Per Share (EPS)	1.61

Full Income Statement

Balance Sheet

The company has 96.35 million in cash and 832.64 million in debt, giving a net cash position of -736.29 million.

Cash & Cash Equivalents	96.35M
Total Debt	832.64M
Net Cash	-736.29M
Net Cash Per Share	n/a
Equity (Book Value)	537.26M
Book Value Per Share	9.91
Working Capital	270.63M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 144.32 million and capital expenditures -34.52 million, giving a free cash flow of 109.80 million.

Operating Cash Flow	144.32M
Capital Expenditures	-34.52M
Free Cash Flow	109.80M
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 62.52%, with operating and profit margins of 18.28% and 8.64%.

Gross Margin	62.52%
Operating Margin	18.28%
Pretax Margin	13.16%
Profit Margin	8.64%
EBITDA Margin	20.70%
EBIT Margin	18.28%
FCF Margin	10.94%

Dividends & Yields

This stock pays an annual dividend of 0.77, which amounts to a dividend yield of 2.20%.

Dividend Per Share	0.77
Dividend Yield	2.20%
Dividend Growth (YoY)	3.06%
Years of Dividend Growth	n/a
Payout Ratio	45.74%
Buyback Yield	0.06%
Shareholder Yield	2.26%
Earnings Yield	5.34%
FCF Yield	6.76%

Dividend Details

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

LON:0A5J has an Altman Z-Score of 2.19 and a Piotroski F-Score of 8. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	2.19
Piotroski F-Score	8